Elanco Animal Health shares are trading lower. The company announced updates to the expected FDA approval timelines for Zenrelia and Credelio Quattro.
Portfolio Pulse from Benzinga Newsdesk
Elanco Animal Health shares are trading lower following updates to the expected FDA approval timelines for Zenrelia and Credelio Quattro.
June 27, 2024 | 12:41 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Elanco Animal Health shares are trading lower due to delays in FDA approval timelines for Zenrelia and Credelio Quattro.
The delay in FDA approval timelines for key products Zenrelia and Credelio Quattro is likely to negatively impact investor sentiment and short-term stock performance for Elanco Animal Health.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100